Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 22.06.2026 3 Am J Dermatopathol 2 Ann Surg Oncol 2 Br J Cancer 1 Cancer 1 Cancer Res 3 J Am Acad Dermatol 4 Melanoma Res 2 Oncogene 1 Ophthalmol Retina 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. STEGURA C, Steevens N, Neimy H, Saravanan S, et al
   Assessing Nuclear and Nucleolar Areas Between Malignant Melanoma and Benign Nevi.
   Am J Dermatopathol. 2026 Jun 18. doi: 10.1097/DAD.0000000000003355.
   PubMed         Abstract available
   
   
2. YU Y, Sabljic T, Capo-Chichi JM, Kamil ZS, et al
   A Novel PDZRN3::BRAF Fusion as Potential Driver Mechanism in BAP1-inactivated Melanocytoma.
   Am J Dermatopathol. 2026 Apr 17. doi: 10.1097/DAD.0000000000003303.
   PubMed         Abstract available
   
   
3. GUNGOR SAHIN G, Eroglu E, Buyukbabani N, Ozturk Sari S, et al
   Comprehensive Immunohistochemical Analysis of Atypical Fibroxanthoma: Focus on PRAME in Differential Diagnosis.
   Am J Dermatopathol. 2026;48:509-514.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. HIEKEN TJ, Flotte TJ, Zahrieh D, Johnson JE, et al
   ASO Visual Abstract: Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma-Results from the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy.
   Ann Surg Oncol. 2026 Jun 17. doi: 10.1245/s10434-026-19981.
   PubMed        
   
   
5. AW K, Lau R, Wong B, Riad K, et al
   ASO Visual Abstract: The Impact of a Regional Communities of Practice to Improve Quality of Melanoma Care: Setting Guidelines for Preoperative Diagnostic Imaging in Early-Stage Melanoma.
   Ann Surg Oncol. 2026 Jun 14. doi: 10.1245/s10434-026-19925.
   PubMed        
   
   

   
   Br J Cancer

6. D'MELLOW M, Wang H, Palmer JM, Hemminki K, et al
   GWAS meta-analysis provides new insights into uveal melanoma risk.
   Br J Cancer. 2026 Jun 16. doi: 10.1038/s41416-026-03499.
   PubMed         Abstract available
   
   
7. BREEZE SO, Heaton MJ, Snelling AP, Garioch JJ, et al
   Implications of wait times for sentinel node biopsy on melanoma disease progression, micrometastatic tumour burden and survival outcomes in the modern treatment era.
   Br J Cancer. 2026 Jun 16. doi: 10.1038/s41416-026-03497.
   PubMed         Abstract available
   
   

   
   Cancer

8. LAWRENCE L
   No RFS benefit found from adding vibostolimab to pembrolizumab in patients with high-risk melanoma: Adding the anti-TIGIT antibody vibostolimab to adjuvant pembrolizumab failed to improve recurrence-free survival and increased toxicity.
   Cancer. 2026;132:e70439.
   PubMed        
   
   

   
   Cancer Res

9. AMBROSINI G, Do C, Tycko B, Realubit RB, et al
   Editor's Note: Inhibition of NF-kappaB-Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma.
   Cancer Res. 2026;86:3092.
   PubMed        
   
   

   
   J Am Acad Dermatol

10. NASSIEF G, Kaelber D, Nowacki AS, Arbesman J, et al
    Genetic predisposition to malignancy confers different outcomes in malignant cutaneous melanoma: A retrospective cohort matched study using TriNetX.
    J Am Acad Dermatol. 2026 Jun 18:S0190-9622(26)02943.
    PubMed        
    
    
11. BRODELL RT
    JAAD Game Changers: "Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study".
    J Am Acad Dermatol. 2026 Jun 15:S0190-9622(26)02894.
    PubMed        
    
    
12. JUNG M, Sharma AN
    Global trends in melanoma incidence and disability burden among young adults by socioeconomic development level using Global Burden of Disease data.
    J Am Acad Dermatol. 2026 Jun 12:S0190-9622(26)02887.
    PubMed        
    
    

    
    Melanoma Res

13. TOMMASINO N, Costa C, Villani A, Menna L, et al
    Twenty-one years of cutaneous melanoma: stage shift, anatomical patterns and diagnostic trends from a Southern European tertiary center.
    Melanoma Res. 2026 Jun 12. doi: 10.1097/CMR.0000000000001115.
    PubMed         Abstract available
    
    
14. SCALA M, Lorente-Estelles D, Liguori L, Juan-Fita MJ, et al
    Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanoma.
    Melanoma Res. 2026 Jun 16. doi: 10.1097/CMR.0000000000001113.
    PubMed         Abstract available
    
    
15. SODERHOLM M, Moberg A, Falk M
    Factors to consider in a primary care setting when using convolutional neural network tools for melanoma diagnostics: a retrospective analysis of images and patient characteristics.
    Melanoma Res. 2026 May 29. doi: 10.1097/CMR.0000000000001110.
    PubMed         Abstract available
    
    
16. ZHUANG W, Liu K, Wang S, Zhang M, et al
    Schisandrin C suppresses melanoma growth and metastasis through modulation of Rap1-related and phosphatidylinositol 3-kinase/protein kinase B/mechanistic target of rapamycin signaling pathways.
    Melanoma Res. 2026 Jun 17. doi: 10.1097/CMR.0000000000001116.
    PubMed         Abstract available
    
    

    
    Oncogene

17. FAJARDO AF, Gowda CP, Johnson E, Petroni R, et al
    In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis.
    Oncogene. 2026 Jun 17. doi: 10.1038/s41388-026-03851.
    PubMed         Abstract available
    
    
18. WANG J, Wee Y, Jacob T, Rogers A, et al
    Rapid activation of ARF6 after RAF inhibition augments BRAF(V600E) and promotes therapy resistance.
    Oncogene. 2026;45:2286-2298.
    PubMed         Abstract available
    
    

    
    Ophthalmol Retina

19. ZHENG JL, Balikov DA, Bowen RC
    Ciliary Body Leiomyoma Mimicking Uveal Melanoma.
    Ophthalmol Retina. 2026 Jun 17:S2468-6530(26)00263.
    PubMed        
    
    

    
    PLoS One

20. WUTTITHANTAWEE Y, Wuttithantawee A, Wuttithantawee R, Pumpong P, et al
    Upregulation of RPLP1 in PBMCs as a screening biomarker for melanoma.
    PLoS One. 2026;21:e0350742.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum